BDBM681294 N-(4-(((R)-1-Hydroxy-4-methylpentan-2-yl)amino)-6-(2-(2-methyl-3-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)propyl)-1,3,5-triazin-2-yl)methanesulfonamide::US20240199558, Example 130

SMILES CC(C)C[C@H](CO)Nc1nc(CC(C)c2ccc3CC(=O)N(C)Cc3c2)nc(NS(C)(=O)=O)n1

InChI Key InChIKey=ZIICDSQFJCTLDT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 681294   

TargetCX3C chemokine receptor 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM681294(US20240199558, Example 130 | N-(4-(((R)-1-Hydroxy-...)
Affinity DataIC50: 79nMAssay Description:CHO-hCX3CR1 membranes (5 μg per well) together with different concentrations of antagonistic compound were incubated in 50 mM HEPES (pH 7.4), 10...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent